Approval · Notice of Compliance 24827 · 2020
DECTOMAX: Notice of Compliance 24827
Issued December 18, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24827
- Date
- December 18, 2020
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in formulation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DECTOMAX | 02231083 | Marketed |
Medicinal ingredients
- DORAMECTIN 10 MG per ML